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Abstract 
Purpose A possible relationship between exposure to formaldehyde and leukaemia particularly 
myeloid leukaemia as well as of lymphoid neoplasms has been debated and is still controversial. 
We thus examined the issue using data from a cohort of workers of a laminated plastic factory sited 
in Piedmont, northern Italy. 
Methods The study cohort included 2,750 subjects (2,227 men and 523 women) who worked in the 
factory between 1947 and 2011, for at least 180 days. Follow-up ended in May 2011, for a total of 
70,933 person-years of observation. We computed standardized mortality ratios (SMR) and 95% 
confidence intervals (CI) using national and (whenever available) Piedmont Region death rates. 
Results Overall, there were 417 deaths versus 493.4 expected ones (SMR = 84.5, 95% CI 76.6–
93.0). The SMRs were 79.8 (95% CI 67.5–93.6) for total cancer mortality, 148.5 (95% CI 68.0–
282.2) for oral cavity and pharynx (three deaths were registered, but not confirmed, as 
nasopharyngeal cancer), 48.3 (95% CI 13.1–123.7) for pancreas, 66.1 (95% CI 13.6–193.0) for 
larynx, and 96.7 (95% CI 72.0–127.2) for lung cancer. The SMR of all lymphohematopoietic 
malignancies was 68.6 (95% CI 31.4–130.3; nine observed deaths). This tended to increase with 
duration of exposure and to decrease with period at first exposure, always remaining below 100. 
There were four deaths from lymphoma (SMR = 74.1, 95% CI 20.1–189.6) and five deaths from 
leukemia (SMR = 92.4, 95% CI 29.9–215.3). 
Conclusions We found no meaningful excess mortality from any lymphohematopoietic nor other 
neoplasms, except possibly for nasopharyngeal cancer. 
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Introduction 
 
In the European Union alone, about 1 million workers were occupationally exposed to variable 
doses of formaldehyde in the early 1990s [1]. Formaldehyde exposure occurs in various industrial 
settings, including manufacture of furniture and fixtures, wood products, wearing apparel and 
textiles, chemicals, and plastic products, as well as in several services such as medical, dental, and 
veterinary ones [2,3]. 
A causal relationship between formaldehyde exposure and leukaemia particularly of the myeloid 
type and other lymphoid neoplasms is controversial [3-10]. Two large US studies published during 
2009, one of workers of ten formaldehyde-using or formaldehyde-producing plants [5] and one of 
professionals of the funeral industry [8], provided evidence for a role of  formaldehyde on myeloid 
leukemia. Besides confirming the overall evaluation of formaldehyde as ‘‘carcinogenic to humans 
(Group 1),’’ a recent International Agency for Research on Cancer (IARC) Monograph concluded 
that there is adequate evidence for a causal role of formaldehyde on leukemia, though not all the 
members of the Working Group agreed [3].  On  the  other  hand, a systematic review  published 
during 2012 concluded for a lack of consistent or strong evidence for any lymphohematopoietic 
cancer [7]. The issue has been widely debated [5, 8, 11-14] and is still open to discussion. 
In 2006, a IARC Working Group evaluated that enough epidemiological evidence was available 
that formaldehyde causes cancer of the nasopharynx in humans [15]. This conclusion was 
confirmed in the subsequent Monograph 100F [3]. The association with other cancers, including 
oral cavity, pancreas, larynx, lung, and brain, is inconsistent [6]. Therefore,  we  examined  the  data  
from  a  cohort  of workers of a laminated plastic factory sited in Piedmont, northern Italy, in order 
to provide further information on the effect of occupational exposure to formaldehyde on mortality 
from cancer, with particular focus on lymphohematopoietic neoplasms. 
 
 
Methods 
 
The study cohort included 3,126 subjects (2,558 men and 568 women) who worked in an Italian 
laminated plastic factory between 1947 and 2011, i.e., present in 1947 or hired thereafter. Subjects 
who worked for <180 days (i.e., 6 months)  at the  factory  (n = 362, 11.6%),  those with missing 
information on  the  date of first  employment (n = 10, 0.3%), and those lost to follow-up with 
available information on the date of first employment only (n = 4, 0.1%) were excluded from the 
cohort, leaving 2,750 subjects (2,227, 81.0% men and 523, 19.0% women) under investigation. 
These were followed-up until 31 May 2011 or until reaching 85 years of age, if this occurred earlier. 
A total of 2,208 (80.3%) subjects survived to the end of the follow-up period, 457 (16.6%) died, and 
85 (3.1%) emigrated or were lost to follow-up for other causes, these being included in the study up 
to the latest date of available information. Overall, 70,933 person-years of observation (57,036 
man-years and 13,897 woman-years) were included in the present analysis. 
We obtained the employment data from personnel records at the factory, and ascertained vital status 
and causes of death through population registers and copies of death certificates from municipal 
registration offices. Information was available on sex, dates of birth, employment(s), migration(s), 
and death, on cause of death and contributory causes and, for over 85 % of subjects, on job category 
(i.e., blue-or white-collar worker). Cause of death could not be retrieved for 26 out of 457 (5.7 %) 
deceased subjects. For 53 (1.9 %) subjects, information on the date at last cessation of employment 
was missing. The latter subjects were kept into all analyses, except those on duration  and  time  
since last exposure. Most  subjects (n = 2,579, 93.8% of the cohort) had only one period of 
employment in the factory. Therefore, we calculated the duration of exposure for all subjects using 
only the date of first hiring and last termination of employment. Anyway, we conducted a 
sensitivity analysis on the duration of exposure by excluding the 171 subjects that had more than 
one period of employment. 
The factory was founded in 1946. Its main product is high-pressure plastic laminate (HPPL) used in 
the furniture industry, hospital equipment, floors, and walls. The raw materials used in the 
production of HPPL laminates are phenolic resin, melamine resin, decorative papers, and kraft 
papers. None of these products can be classified according to the material safety data sheets as a 
highly toxic substance. 
Figure 1 shows the scheme blocks of the production process. Technical measures that were adopted 
to reduce the risks from substances in the workplace include (1) segregated operations for 
impregnation of papers; (2) aspiration of volatile organic compounds at the point of release; (3) 
utilization of locked machinery and automatic procedures, when possible; and (4) use of personal 
protective equipment. A further improvement of the working environment was obtained by 
replacing the phenolic resin in solvent with the phenolic resin in water in 1991. The major chemical 
risk, mainly in the past, is due to formaldehyde exposure. Formaldehyde is a by-product from resins 
in the phase of machining. 
 
Data analysis 
 
We computed expected number of deaths from lymphohematopoietic and other neoplasms, as well 
as total mortality, using the Piedmont Region deaths rates [16, 17] from 1981 onwards, and the 
national death rates before 1980 [18], by sex, 5-year calendar period, and age group. As Piedmont 
Region (and Italian) death rates were not available for 2004–2005 and after 2010, we applied those 
of 2001–2003 to the period 2000–2004 and those of 2006–2010 to the period 2005–2011 (i.e., the 
central years of the two periods). We computed the standardized mortality ratios (SMR) of various 
cancers and total mortality separately by sex and overall, as the ratio of observed and expected 
numbers of deaths, multiplied by 100. For lymphohematopoietic neoplasms, we also computed the 
SMRs according to several  factors related to employment. The Poisson distribution was used to 
compute the confidence intervals (CI) for up to 10 observed deaths, and the normal approximation 
for >10 observed deaths [19]. The causes of death were coded according to the Ninth Revision of 
the International Classification of Diseases (ICD-IX). 
 
Results 
 
Table 1 shows the number of observed and expected deaths from various lymphohematopoietic 
cancers, separately for men and women, and the corresponding SMR and 95% CI. SMRs are 
presented for men and women combined, too. Seven male deaths from all lymphohematopoietic 
malignancies combined were reported, as compared to 11.6 expected on the basis of  population 
mortality  rates (SMR = 60.2, 95% CI 24.1–124.0). The corresponding observed and expected 
deaths in women were 2 and 1.5, respectively (SMR = 134.1, 95% CI 16.2–484.2). The overall 
SMR of lymphohematopoietic malignancies was thus 68.6 (95% CI 31.4–130.3). With reference to 
the type of lymphohematopoietic malignancy, there were four deaths from lymphoma (all non-
Hodgkin) versus 5.4 expected ones (SMR = 74.1, 95% CI 20.1–189.6)  and five deaths from 
leukemia (three myeloid and two of unspecified  cell  type)  versus 5.4 expected ones (SMR = 92.4, 
95% CI 29.9–215.3). No death from multiple myeloma was reported, as compared to 2.3 expected 
ones. 
Table 2 reports the observed  deaths from lymphohematopoietic malignancies (excluding multiple 
myeloma), and the corresponding SMRs and 95% CIs, according to several, mainly time-related, 
characteristics of employment. The SMR of all lymphohematopoietic cancers tended to increase 
with duration of exposure (from 54.6 for <10 years to 90.1 for ≥20 years) and to decrease with 
period at first exposure (from 90.6 for first exposure before 1970 to 0.0 from 1980 onwards), being 
in any case lower than 100. All lymphoma deaths occurred 10 or more years after exposure ceased 
(SMR = 147.1) and in subjects first employed before 1970 (SMR = 128.6). For leukemia, the SMRs 
tended to increase with age at first exposure (from SMR = 0.0 for first exposure before age 25 years 
to SMR = 149.8 at 35 years or more) and to decrease with time since last exposure (from SMR = 
152.7 for current exposure to SMR = 68.3 for 10 or more years since stopping exposure). Almost 
90% of total person-years and eight out of nine deaths from lymphohematopoietic cancers occurred 
in blue-collar workers [i.e., 2,133 out of 2,389 (89.3%) subjects for which the information on job 
category was available]. 
Table 3 shows the observed and expected numbers of deaths from several cancers and all causes, 
and the corresponding SMR and 95% CI. A total of 417 deaths occurred before age 85 years. On the 
basis of mortality rates, 493.4 deaths were expected; thus, the corresponding SMR was 84.5 (95% 
CI 76.6–93.0). The SMR for total cancer mortality was 79.8 (95% CI 67.5–93.6; 149 observed 
deaths). With reference to the main cancer sites of interest, the SMRs were 148.5 (95% CI 68.0–
282.2; nine observed deaths, of which three were from nasopharyngeal cancer) for oral cavity and 
pharynx, 70.6 (95% CI 32.3–134.1; nine observed deaths) for stomach, 88.6 (95% CI 51.7–141.8; 
17 observed deaths) for colorectum, 48.3 (95% CI 13.1–123.7; four observed deaths) for pancreas, 
66.1 (95% CI 13.6–193.0; three observed deaths) for larynx, 96.7 (95 % CI 72.0–127.2; 51 
observed deaths) for lung, 150.6 (95% CI 72.3–277.1; 10 observed deaths) for bladder, 96.4 (95% 
CI 26.2–246.7; four observed deaths) for kidney, and 41.1 (95% CI 5.0–148.3; two observed deaths) 
for brain cancer. No deaths were reported from nasal cavity and paranasal sinus cancer. 
 
Discussion 
 
In this cohort of workers exposed to formaldehyde, no excess in mortality from leukemia and 
lymphoid neoplasms was reported. In fact, the SMR for all lymphohematopoietic neoplasms was 
lower than 100. When we restricted the analyses to blue-collar workers only, i.e., those subjects 
more likely of having experienced formaldehyde exposure, the results were materially unchanged. 
Further, no clear pattern of risk emerged when we examined time-related factors of exposure and 
mortality from lymphohematopoietic cancers. The latter analyses were, however, limited by the 
relatively small numbers in each subgroup. With reference to leukemia subtypes, there were three 
deaths from the myeloid type. In the absence of specific mortality rates, the proportion of the 
myeloid leukemia subtype in Italy was about 40 % both in the late 1980s [20] (mortality data) and 
in 2003–2005 [21] (incidence data). Assuming that the proportion has remained stable over the 
whole follow-up period, and that the age distribution in adults resembles that of total leukemia, 
about 2–2.5 deaths were expected from myeloid leukemia, as compared to three observed deaths. 
The corresponding SMR would thus range between 120 and 150. It is, however, difficult to 
disentangle leukemia subtypes using mortality data, since 15–30 % of deaths from leukemia in most 
European countries, including Italy, are of undefined subtype [22]. We do not have information on 
the dose of formaldehyde exposure in this cohort, and thus, our data cannot rule out an effect at 
doses higher than those occurring in these workers. 
The IARC classified formaldehyde as carcinogenic to humans [3, 15]. In the evaluation of the 
epidemiological evidence, the Working Group concluded that sufficient data were available for a 
causal relation with nasopharyngeal neoplasm [15]. Other reviews and meta-analyses of the 
available evidence on formaldehyde and cancer risk suggested a modest excess risk of 
nasopharyngeal cancer, due to a cluster of deaths in one US plant of the NCI Cohort study [6, 23, 
24]. It was hypothesized that the excess mortality in that cohort was due to prior exposure to metal 
working rather than to formaldehyde exposure [25]. This notwithstanding, a recent update of the 
NCI Cohort investigation confirmed an excess of nasopharyngeal cancer for peak, average intensity, 
and cumulative exposure [23]. In our study, 3 deaths from nasopharyngeal cancer were reported. 
Population mortality rates were available for most of the follow-up period only for oral and 
pharyngeal cancer as a whole (ICD-IX: 140–149). Thus, we could not calculate the expected deaths 
and SMR for nasopharyngeal cancer. However, about 5–10% of all Italian deaths from oral and 
pharyngeal cancer were of the nasopharynx in the 1980s and 1990s [20, 26, 27]. In Piedmont, in the 
periods 2001–2003 and 2006–2010, the corresponding proportion was 5–6% [17]. Therefore, 
approximately 0.3–0.6 deaths were expected from nasopharyngeal cancer, with the corresponding 
SMR ranging between 500 and 1,000. All the 3 deaths occurred in males first employed before 
1970, when exposure levels were likely to be higher [15]. Therefore, this study is in line with a 
possible excess in mortality from nasopharyngeal cancer in workers exposed to formaldehyde. 
Given the rough calculation method used, caution is however needed in the interpretation of these 
results. Furthermore, nasopharyngeal cancers were not histologically confirmed in this study. This 
cohort was set in a rural setting, and potential higher exposure of subjects to Epstein–Barr virus 
(e.g., contact with farm animals) may be a confounding factor [28]. 
With reference to other cancer sites, some studies indicated a possible increase in risk of nasal [29, 
30], lung [31, 32], and brain cancer [33–35] in formaldehyde-exposed professionals or industry 
workers, but results were generally inconsistent [6, 23, 36]. Our data do not support any of these 
associations. 
Among the limits of this study there are the unavailability of exposure measurements or other 
indices of formaldehyde exposure, apart from the duration of employment and type of occupation 
(i.e., blue- or white-collar worker), the lack of specific SMR estimates for myeloid leukemia and 
nasopharyngeal cancer, and the limited power for subgroup analyses on lymphohematopoietic 
neoplasms. Cause of death was missing for about 6% of deceased subjects, mainly because death 
occurred outside Italy or death certificate could not be found by competent authorities. The 
Piedmont Region, and particularly the Tanaro River area where the factory is sited, was affected by 
a ruinous flood in 1994 that, in fact, damaged a number of registration archives. Main strengths of 
this study are its relatively large size, the long follow-up period covering  about  65 years  (i.e., 
from 1947 to 2011, median 23.6 years), and the completeness of follow-up information that was 
available for over 95% of subjects in the cohort. 
In conclusion, this cohort study of workers of an Italian laminated plastic factory reported no excess 
mortality from lymphohematopoietic neoplasms overall nor, when considered separately, from 
lymphoma, myeloma, and leukemia. Overall mortality in the cohort was about 15% lower than in 
the general population, possibly explained by the healthy worker effect [37]. However, total cancer 
mortality, which is not affected by the healthy worker effect, was decreased by about 20% among 
workers of the factory. No meaningful excess mortality from any type of neoplasm emerged, except 
possibly for cancer of the nasopharynx (three observed deaths), in the absence however of precise 
estimates of the SMR. 
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Fig. 1 
Scheme blocks of the production process 
 
 
 
 
 
Table 1  
Observed and expected deaths from lymphohematopoietic malignancies, and corresponding standardized mortality 
ratios (SMR) and 95 % confidence intervals (CI), in a cohort of laminated plastic workers (Italy, 1947–2011) 
 
 
Deaths and person-years occurring at age C85 years are excluded. Cause of death was unknown for 24 out of 417 subjects (5.8 %) who died before 
age 85 (all 24 were males) 
 
 
 
Table 2  
Observed deaths (O) from lymphohematopoietic malignancies, and corresponding standardized mortality ratios (SMR), 
according to various characteristics of exposure in a cohort of laminated plastic workers (Italy, 1947–2011) 
 
 
Deaths and person-years occurring at age C85 years are excluded L/H lymphatic and hematopoietic tissue neoplasms 
a 53 out of 2,750 subjects (1.9 %) were excluded from these analyses because information on the date at last exposure was missing 
b 361 out of 2,750 subjects (13.1 %) were excluded from this analysis because information on the type of occupation was missing 
 
 
 
 
 
 
 
 
Table 3  
Observed and expected deaths from other (non-lymphohematopoietic) cancers, and corresponding standardized 
mortality ratios (SMR) and 95 % confidence intervals (CI), in a cohort of laminated plastic workers (Italy, 1947–2011) 
 
 
In bold, statistically significant results (95 % CI) 
Deaths and person-years occurring at age C85 years are excluded. Cause of death was unknown for 24 out of 417 subjects (5.8 %) who died before 
age 85 (all 24 were male deaths) 
a There were 3 deaths from nasopharyngeal cancer (all males 
